[Oral drops: unsafe or unwieldy method of administration?]

Area of Science:

• Pharmacovigilance
• Patient Safety
• Pharmaceutical Care

Background:

• A serious pipamperone overdose in a pediatric patient highlighted administration errors.
• The incident involved medication administered in streams instead of drops, leading to overdose.

Purpose of the Study:

• To describe the use of drops in pharmaceutical patient care.
• To explain the Netherlands Medicines Evaluation Board's (MEB) decision to maintain marketing authorization for pipamperone.
• To underscore the importance of reporting medication errors.

Main Methods:

• Review of a specific pipamperone overdose case.
• Analysis of pharmaceutical practices involving liquid medication administration.
• Evaluation of existing marketing authorization based on current data.

Main Results:

• The MEB identified the cause of the overdose as incorrect administration (streams vs. drops).
• Marketing authorization for pipamperone was maintained based on available information.
• A call for reporting of all drug use problems to relevant safety centers was issued.

Conclusions:

• Accurate medication administration is critical for patient safety.
• Continued vigilance and reporting of medication errors are essential for pharmacovigilance.
• The MEB's decision reflects a balance between safety concerns and product availability.